The Allstate Corporation (ALL)

FairStock Score: 90/100 — HIGH CONVICTION

Key Financials

Strengths

• Exceptional Q4 2025 profitability with 22.28% net margin on $17.2B revenue
• Strong balance sheet with 0.25 D/E ratio and $8.9B free cash flow generation
• Diversified distribution network across exclusive agents, independents, and digital channels
• 39.52% ROE demonstrates historical capital efficiency despite ROCE concerns
• FairStock Score of 78/100 and consistent dividend payments suggest institutional quality

Concerns

• No margin of safety: stock trades 8.18% above Graham Number intrinsic value
• Alarming Altman Z-Score of 1.24 indicates potential financial distress signals
• Disconnection between reported 39.5% ROE and 6.49% ROCE suggests accounting opacity
• Piotroski F-Score of 6/9 reflects deteriorating operational and financial quality metrics

AI Analysis

Allstate presents an intriguing paradox that demands careful scrutiny. On the surface, the numbers seduce: a P/E of 5.4 suggests deep value, and that 39.5% ROE rivals exceptional businesses. The latest quarter delivered a 22.3% net margin on $17.2B revenue—impressive operational leverage. With $8.9B in free cash flow and a conservative 0.25 debt-to-equity ratio, the balance sheet is fortress-like. The company's diversified distribution model across exclusive agents, independents, and digital channels provides genuine competitive advantages in a fragmented industry. However, I must temper my enthusiasm. The Graham Number sits at $196.27 against a $212.32 price—no margin of safety exists here. More troubling is the Altman Z-Score of 1.24, suggesting financial distress territory. The Piotroski F-Score of 6/9 indicates moderating quality. The ROCE of 6.49% is disappointing for a business claiming such returns on equity—this disconnect warrants investigation into accounting treatments. Insurance is inherently cyclical; underwriting discipline varies with the insurance cycle. While Allstate has weathered storms admirably, I cannot ignore that we're likely in the benign phase of the cycle. The 0.21 beta suggests low volatility, but this may reflect a mature, slowly-growing business rather than genuine defensive strength.

Bull Case

If the insurance cycle remains benign and underwriting discipline holds, Allstate's exceptional margin performance could sustain, validating the low P/E multiple. The fortress balance sheet and massive free cash flow ($8.9B annually) provide both downside protection and optionality for capital returns or strategic acquisitions.

Bear Case

The Altman Z-Score warning combined with low ROCE relative to reported ROE suggests deteriorating business quality masked by cyclical profitability. If catastrophe losses accelerate or underwriting discipline erodes, the valuation multiple will contract sharply, particularly given the absence of a margin of safety.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer